Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies

Aimed to elaborate new group of protein kinase inhibitors we conducted receptor-based screening (docking, QSAR modeling) and biochemical testing for derivatives of (2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thiones. Methods and results. This study allowed identifying of new potential antican...

Full description

Bibliographic Details
Main Authors: I. S. Nosulenko, O. Yu. Voskoboynik, O. M. Antypenko, G. G. Berest, S. I. Kovalenko
Format: Article
Language:English
Published: Zaporozhye State Medical University 2015-02-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/39873/36005
id doaj-f1825b40355847be9ee7c30c9c75ad3f
record_format Article
spelling doaj-f1825b40355847be9ee7c30c9c75ad3f2020-11-24T22:19:03ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102015-02-01199104http://dx.doi.org/10.14739/2310-1210.2015.1.39873Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studiesI. S. Nosulenko O. Yu. Voskoboynik O. M. AntypenkoG. G. BerestS. I. KovalenkoAimed to elaborate new group of protein kinase inhibitors we conducted receptor-based screening (docking, QSAR modeling) and biochemical testing for derivatives of (2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thiones. Methods and results. This study allowed identifying of new potential anticancer compounds among (2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thiones’ derivatives. Conclusion. Obtained data may be used for the development of more active and selective inhibitors of protein CK2 kinase. Besides that QSAR-models which were created may be used for planning of chemical modification of structure aimed to creation of new anticancer agents.http://zmj.zsmu.edu.ua/article/view/39873/36005QuinazolinesTriazinesCasein Kinase IIQuantitative Structure-Activity RelationshipMolecular Docking Simulation
collection DOAJ
language English
format Article
sources DOAJ
author I. S. Nosulenko
O. Yu. Voskoboynik
O. M. Antypenko
G. G. Berest
S. I. Kovalenko
spellingShingle I. S. Nosulenko
O. Yu. Voskoboynik
O. M. Antypenko
G. G. Berest
S. I. Kovalenko
Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
Zaporožskij Medicinskij Žurnal
Quinazolines
Triazines
Casein Kinase II
Quantitative Structure-Activity Relationship
Molecular Docking Simulation
author_facet I. S. Nosulenko
O. Yu. Voskoboynik
O. M. Antypenko
G. G. Berest
S. I. Kovalenko
author_sort I. S. Nosulenko
title Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
title_short Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
title_full Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
title_fullStr Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
title_full_unstemmed Methodology for prediction of anticancer action of (2-oxo-2H-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via QSAR and docking studies
title_sort methodology for prediction of anticancer action of (2-oxo-2h-[1,2,4]¬triazino[2,3-c]-quinazolin-6-yl)thiones via qsar and docking studies
publisher Zaporozhye State Medical University
series Zaporožskij Medicinskij Žurnal
issn 2306-4145
2310-1210
publishDate 2015-02-01
description Aimed to elaborate new group of protein kinase inhibitors we conducted receptor-based screening (docking, QSAR modeling) and biochemical testing for derivatives of (2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thiones. Methods and results. This study allowed identifying of new potential anticancer compounds among (2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)thiones’ derivatives. Conclusion. Obtained data may be used for the development of more active and selective inhibitors of protein CK2 kinase. Besides that QSAR-models which were created may be used for planning of chemical modification of structure aimed to creation of new anticancer agents.
topic Quinazolines
Triazines
Casein Kinase II
Quantitative Structure-Activity Relationship
Molecular Docking Simulation
url http://zmj.zsmu.edu.ua/article/view/39873/36005
work_keys_str_mv AT isnosulenko methodologyforpredictionofanticanceractionof2oxo2h124triazino23cquinazolin6ylthionesviaqsaranddockingstudies
AT oyuvoskoboynik methodologyforpredictionofanticanceractionof2oxo2h124triazino23cquinazolin6ylthionesviaqsaranddockingstudies
AT omantypenko methodologyforpredictionofanticanceractionof2oxo2h124triazino23cquinazolin6ylthionesviaqsaranddockingstudies
AT ggberest methodologyforpredictionofanticanceractionof2oxo2h124triazino23cquinazolin6ylthionesviaqsaranddockingstudies
AT sikovalenko methodologyforpredictionofanticanceractionof2oxo2h124triazino23cquinazolin6ylthionesviaqsaranddockingstudies
_version_ 1725780323921297408